Streamlined ADC Development Facility
A specialized facility dedicated to the manufacturing of antibody-drug conjugates (ADCs) offers a cohesive approach from the initial stages of conjugation development to the final formulation. This state-of-the-art site is equipped with advanced reactor systems, both single-use and stainless steel, capable of supporting conjugation processes up to 500 liters.
The facility encompasses fully equipped laboratories focused on ADC development, quality control (QC), and manufacturing science and technology (MSAT). It is specifically designed to manage high-potency active pharmaceutical ingredients (HPAPIs) while implementing stringent containment protocols. This includes achieving an Occupational Exposure Limit (OEL) of 5 ng/m³, ensuring safety and compliance throughout the manufacturing process.
Comprehensive Services from a Reliable CDMO
As an industry leader in the development and manufacturing of ADCs, Samsung Biologics provides a full spectrum of services. From antibody production and conjugation development to large-scale manufacturing, our expertise guarantees that each phase of the ADC lifecycle is executed with precision and adherence to regulatory standards.
Our flexible and agile approach to ADC development is tailored for efficiency and speed. By employing dedicated teams and streamlined workflows, we significantly reduce timelines, achieving a complete development cycle—from cell line creation to ADC formulation—in as little as 12 months.
Optimized Development Toolbox
The development of ADCs requires meticulous attention to detail, particularly in method optimization and control of drug-to-antibody ratios (DAR). Our facility utilizes advanced methods to enhance stability and develop lyophilization processes, ensuring that each ADC is robust and effective.
The expert team at Samsung Biologics constructs customized timelines that cater to the unique requirements of each client. This approach allows for flexibility at every stage, from monoclonal antibody thawing through to formulation and bulk fill-finish operations.
Integrated Analytical Testing
At Samsung Biologics, we prioritize quality and efficiency by conducting all essential analytical tests for ADC development in-house. This integrated strategy fosters collaboration between the ADC development and manufacturing teams, ensuring consistent quality control and streamlined processes.
This cohesive approach not only simplifies the workflow but also enhances the reliability of results, enabling us to meet the highest industry standards.
Tailored Development Journeys
We understand that each client has distinct needs and goals. Therefore, we offer customized development journeys that align with specific project objectives. By integrating our services from the initial concept through to commercial production, we ensure that every aspect of ADC development is tailored to maximize potential.
This client-centric philosophy guarantees that our partners receive the best possible support throughout the entire lifecycle of their ADC projects.
Conclusion
The development and manufacturing of antibody-drug conjugates is a complex yet rewarding process. Through our dedicated facilities and integrated services, we empower our clients to realize the full potential of their ADCs. With an emphasis on agility, precision, and quality, Samsung Biologics stands as a trusted partner in the evolving landscape of biopharmaceuticals.
- Expertise in ADC Lifecycle: Comprehensive services from conception to commercialization.
-
Safety and Compliance Focus: Rigorous protocols ensure high safety standards during manufacturing.
-
Tailored Client Solutions: Customized development paths optimize project outcomes.
-
Accelerated Timelines: Efficient workflows reduce development cycles to as little as 12 months.
-
Integrated Quality Assurance: In-house analytical testing enhances reliability and compliance.
Read more → samsungbiologics.com